Compositions and methods for treating cancer
US-2026085074-A1 · Mar 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Shokat Kevan M patents
Shokat Kevan M is listed as an inventor on 62 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Shokat Kevan M |
| Total patents | 62 |
| First publication | Jan 8, 2015 |
| Latest publication | Mar 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Immunophilin binding agents and uses thereof
US-12558356-B2 · Feb 24, 2026 · US
Aurora kinase inhibitors
US-12551482-B2 · Feb 17, 2026 · US
Prostaglandin E synthase 3 (PTGES3) Inhibiting Compounds
US-2026014143-A1 · Jan 15, 2026 · US
Her3 ligands and uses thereof
US-2025388563-A1 · Dec 25, 2025 · US
Chemically controlled monoclonal antibody target engagement
US-12486334-B2 · Dec 2, 2025 · US
Compositions and methods for treating cancer
US-12365693-B2 · Jul 22, 2025 · US
Abl inhibitors and uses thereof
US-2025144224-A1 · May 8, 2025 · US
Immunophilin binding agents and uses thereof
US-2025108052-A1 · Apr 3, 2025 · US
Compositions and methods for treating cancer
US-2025101036-A1 · Mar 27, 2025 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for treating cancer
US-2025092061-A1 · Mar 20, 2025 · US
Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase
US-2025059187-A1 · Feb 20, 2025 · US
Compositions and methods for treating cancer
US-12116375-B2 · Oct 15, 2024 · US
G-alpha-s inhibitors and uses thereof
US-2024336563-A1 · Oct 10, 2024 · US
G-alpha-s peptide inhibitors and uses thereof
US-2024336657-A1 · Oct 10, 2024 · US
Compositions and methods for treating cancer
US-12077507-B2 · Sep 3, 2024 · US
Compositions and methods for treating cancer
US-2024109845-A1 · Apr 4, 2024 · US
Compositions and methods for treating cancer
US-2024067656-A1 · Feb 29, 2024 · US
Compositions and methods for treating cancer
US-11891402-B2 · Feb 6, 2024 · US
Compositions and methods for treating cancer
US-11718630-B2 · Aug 8, 2023 · US
Ras inhibitors and uses thereof
US-2023242586-A1 · Aug 3, 2023 · US
Compositions and methods for treating cancer
US-2023242548-A1 · Aug 3, 2023 · US
Compositions and methods for treating cancer
US-2023135350-A1 · May 4, 2023 · US
Stabilization of mhc complexes
US-2023111132-A1 · Apr 13, 2023 · US
Kinase antagonists
US-2023111917-A1 · Apr 13, 2023 · US
Compositions and methods for treating cancer
US-11603376-B2 · Mar 14, 2023 · US
Immunophilin binding agents and uses thereof
US-2023063768-A1 · Mar 2, 2023 · US
Chemically controlled monoclonal antibody target engagement
US-2022289866-A1 · Sep 15, 2022 · US
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
US-11427588-B2 · Aug 30, 2022 · US
Immunophilin-dependent inhibitors and uses thereof
US-2022193242-A1 · Jun 23, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ California | 62 |
| Mitokinin Llc | 4 |
| Icahn School Med Mount Sinai | 3 |
| Intellikine Inc | 2 |
| Univ Washington | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 49 |
| C07D487/04 | 32 |
| A61P43/00 | 26 |
| G01N2500/04 | 24 |
| C12Y306/05002 | 22 |